Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)

Title
Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)
Authors
Keywords
Antiphospholipid syndrome, Antiphospholipid antibodies, Arterial thrombosis, Thrombin activatable fibrinolysis inhibitor (TAFI), Complement C5a
Journal
THROMBOSIS RESEARCH
Volume 158, Issue -, Pages 168-173
Publisher
Elsevier BV
Online
2017-06-24
DOI
10.1016/j.thromres.2017.06.028

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started